摘要
观察30例原发性肝癌病人血清AFP及SF的治疗前、中及后动态变化,探讨其临床意义。结果发现,AFP>1000ng/ml的初诊病人中,SF异常升高占14/30。同时,通过动态分析,发现SF与病情发展、治疗效果、预后等有关。作者认为,AFP是一定性指标,以此为原发性肝癌主要的诊断依据,而SF则是一重要定量指标,表明疾病的发展程度,不能用于原发性肝癌的定性诊断。
In this article,the dynamic changes of serum AFP and SF at different phases(pre-treatment,during-treatment and post-treatment) were studied in 30 primary hepatic carcinomas(PHC)in order to assess their clinical significance.Our results showed that in untreated PHC Patients(AFP>1000ng/ml),only14/30 had abnormal elevation of SF.Meanwhile,the dynamic analysis showed that SF would indicate the status of disease,effect of treatment and prognosis etc.We consider that AFP is a qualitative indicator which serves as an importantdiagnostic evidence,whereas SF is a quantitative indicator which tells the degree of advancement of the disease,but not a pathognomonic feature of PHC.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1996年第9期644-646,共3页
Chinese Journal of Clinical Oncology
关键词
肝细胞癌
甲胎蛋白
铁蛋白
Primary hepatic carcinoma α-Fetoprotein Serum ferritin